About the Company
Advaxis, Inc. is a clinical-stage biotechnology company focused on the development and commercialization of proprietary Lm-based antigen delivery products. These immunotherapies are based on a platform technology that utilizes live attenuated Listeria monocytogenes (Lm) bioengineered to secrete antigen/adjuvant fusion proteins. These Lm-based strains are believed to be a significant advancement in immunotherapy as they integrate multiple functions into a single immunotherapy and are designed to access and direct antigen presenting cells to stimulate anti-tumor T cell immunity, activate the immune system with the equivalent of multiple adjuvants, and simultaneously reduce tumor protection in the tumor microenvironment to enable T cells to eliminate tumors.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $ADXS News
Advaxis, Inc. (ADXS)
Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...
Advaxis, Inc. (ADXS) Interactive Stock Chart - Yahoo Finance
REHOVOT, Israel and WILMINGTON, Del. and MONMOUTH JUNCTION, N.J., Jan. 19, 2023 (GLOBE NEWSWIRE) -- Advaxis, Inc. (OTCQX: ADXS), a biotechnology company devoted to ...
Advaxis Surges Higher on Additional Institutional Interest
Advaxis stock rallied after a private placement showed added fund participation. Read how this move has rebutted the short thesis. Advaxis stock rallied after a private placement showed added fund ...
Advaxis: Legit Reasons to Take Another Look at Under-Appreciated Cancer Immunotherapy
The hiring of a key Merck scientist and potential for combination cancer immunotherapy explain the recent rebound in Advaxis' stock price. The hiring of a key Merck scientist and potential for ...
Advaxis Stock (OTC:ADXS), Dividends
Advaxis issues dividends to shareholders from excess cash Advaxis generates. Most companies pay dividends on a quarterly basis, but dividends may also be paid monthly, annually or at irregular ...
Cancer Vaccines Market Size and Updated Report Things to Focus on to Ensure Growth Prospects by 2031
Along with R&D, new product launches, mergers and acquisitions, agreements, collaborations, partnerships, joint ventures, and the local improvement of basic competition operating within the market on ...
Dividend Scorecard
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser. Is this happening to you frequently? Please report it on our ...
New Innovations opens Prospects for the Cancer Vaccine Market, Propelling the Growth of Market at 12% CAGR through 2033
The global cancer vaccine market is expected to grow significantly in the coming years, according to a new report published by Future Market Insights. The report predicts that the market will grow at ...
Prostate Specific Antigen Market Size 2023 Research Report by Growth Rate Analysis and Forecast till 2027
Mar 15, 2023 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." Report on the "Prostate Specific ...
Advaxis, Inc. (ADXS) Interactive Stock Chart - Yahoo Finance
REHOVOT, Israel and WILMINGTON, Del. and MONMOUTH JUNCTION, N.J., Jan. 19, 2023 (GLOBE NEWSWIRE) -- Advaxis, Inc. (OTCQX: ADXS), a biotechnology company devoted to the discovery, development and ...
Advaxis, Inc. (ADXS)
*Close price adjusted for splits.**Close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...
Loading the latest forecasts...